Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5Neoplasms 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Mucositis 2Inflammation 2Diarrhea 2Chalazion 2Carcinoma, Hepatocellular 2Stomach Neoplasms 1Smoldering Multiple Myeloma 1Radiation Injuries 1Pelvic Neoplasms 1Pelvic Inflammatory Disease 1Neoplasms, Second Primary 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Malnutrition 1Liver Cirrhosis 1Laryngeal Neoplasms 1Infections 1Generalized Anxiety Disorder 1Fibrosis 1Fatigue Syndrome, Chronic 1Enteritis 1Endotoxemia 1Carcinogenesis 1

Interventions

Vinorelbine 1Probiotics 1Pemetrexed 1Paclitaxel 1Docetaxel 1Cisplatin 1Carboplatin 1Blood Specimen Collection 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinogenesis × Probiotics × Clear all
NCT05544396 2024-11-14

Study on the Probiotics Regulating miRNA in H. Pylori-induced Wnt/β-catenin Gastric Carcinogenesis.

National Cheng-Kung University Hospital

Phase NA Active not recruiting
100 enrolled

Carcinogenesis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡